DE SCR79

Designates March 2022 as "Rare Kidney Disease Awareness Month" in Delaware to raise awareness about conditions like APOL1-mediated focal segmental glomerulosclerosis (FSGS)

Highlights that African Americans represent 13% of the U.S. population but account for 32% of kidney failure cases and 35% of end-stage kidney disease, with four times higher risk than White Americans

Notes that APOL1 genetic variants explain the disproportionate kidney disease rates among people of African ancestry, including African American, Afro-Caribbean, and Latinx populations

Emphasizes that APOL1-mediated FSGS leads to kidney failure in 50% of patients within 5 years, and no approved treatments currently exist to address its underlying cause

Aims to increase public awareness to promote early diagnosis and care for vulnerable populations at risk for rare kidney diseases